CN107899008B - Sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus - Google Patents

Sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus Download PDF

Info

Publication number
CN107899008B
CN107899008B CN201711093087.1A CN201711093087A CN107899008B CN 107899008 B CN107899008 B CN 107899008B CN 201711093087 A CN201711093087 A CN 201711093087A CN 107899008 B CN107899008 B CN 107899008B
Authority
CN
China
Prior art keywords
pig
thr
ser
leu
albumen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201711093087.1A
Other languages
Chinese (zh)
Other versions
CN107899008A (en
Inventor
刘灿
张磊
陈瑞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Nuweilihua Biotechnology Co ltd
Original Assignee
Shaanxi Nuweilihua Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Nuweilihua Biotechnology Co ltd filed Critical Shaanxi Nuweilihua Biotechnology Co ltd
Priority to CN201711093087.1A priority Critical patent/CN107899008B/en
Publication of CN107899008A publication Critical patent/CN107899008A/en
Application granted granted Critical
Publication of CN107899008B publication Critical patent/CN107899008B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention provides a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus sick three subunit vaccines, it include antigen and vaccine adjuvant, wherein antigen is the Porcine epidemic diarrhea virus S1 albumen expressed by the X33-PEDV-S1 strain that deposit number is CGMCC No.14372, the pig fourth type coronavirus S1 albumen for the X33-PDCoV-S1 strain expression that 1 albumen of pig infectious gastroenteritis virus S and deposit number for the X33-TGEV-S1 strain expression that deposit number is CGMCC No.14371 are CGMCC No.14370.Sick three subunit vaccines of pig epidemic diarrhea of the invention, transmissible gastroenteritis of swine, pig fourth type coronavirus are highly-safe, immunogenicity is good, antibody is generated quickly and is held time length compared with antibody titers after immune, vaccine long shelf-life, immunizing dose is small, the adjuvant of selection is easy to inject, can a needle prevent and treat three kinds of main diarrhea related diseases viral diseases, improve the survival rate of piglet.

Description

A kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus disease three Subunit vaccine
Technical field
The invention belongs to veterinary biologics technical fields, and in particular to a kind of pig epidemic diarrhea, pig transmissible stomach and intestine Scorching, sick three subunit vaccines of pig fourth type coronavirus
Background technique
Pig epidemic diarrhea (Porcineepidemicdiarrhea, PED) is the pig as caused by Porcine epidemic diarrhea virus A kind of high degree in contact enteric infectious disease, using diarrhea, vomiting and loss of appetite as essential characteristic, pig of this disease to all ages and classes Susceptible, especially suckling pig endangers most serious, is a kind of highly contagious disease.The disease is starting in Britain in 1971, China first appears the disease within 1986.Since 2010, national pig epidemic diarrhea was in outbreak of epidemic, popular field strain There is variation in strain before comparing 2010, causes huge economic loss to aquaculture.
Transmissible gastroenteritis of swine (Transmissible gastroenteritis, TGE) is a kind of acute intestinal of pig Infectious disease is fallen ill anxious, is propagated fastly, and the pig at various ages can infect, to cause piglet within 3-10 age in days to vomit, seriously Diarrhea, it is thin with high mortality (usual 100%) is characterized, and morbid pig also often shows as acute watery diarrhea, excrement be in yellow or Light green or canescence are mixed with indigested ziega in some suckling pig excrement.The malicious pig of sick pig, band and its excreta, cream Juice, vomitus etc. are the important infection sources, and disease whole year can occur, and various regions are in distribute prevalence in recent years.
Pig fourth type coronavirus (Porcine Deltacoronavirus, PDCoV) belongs to the more virales of Buddhist nun (Nidovirales), the coronal disease of Delta of coronaviridae (Coronaviridae), coronavirus genus (Coronavirus) Poison, to there is the single strand plus RNA virus of cyst membrane.At the beginning of 2014, Ohio, USA reports a kind of new pig enteric coronavirus at first Viral PDCoV, the end of the year current year disease in 17 states in the U.S. it is popular.Then plus by also being reported with South Korea detect PDCoV, positive rate are up to 25%.More importantly the PDCoV clinic of CONTINENTAL AREA OF CHINA is examined between 2014-2016 It surveys positive rate and is up to 23.4%, and there is no corresponding vaccine for the disease.
Infection for pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus disease, there is presently no effective Treatment method, mainly puted prevention first with vaccine immunity.Currently, external is mainly the Attenuate vaccine of South Korea, the country is mainly breathed out TGE, PED and three attenuated live vaccines of rotavirus of beast development, the TGE-PED bigeminy attenuated live vaccines of Da Bei Nong company, The vaccines such as the TGE-PED bivalent inactivated vaccine of Wuhan predecessor company, section, but clinical application effect is limited;In addition, attenuated vaccine with go out Live vaccine exists in production dissipates malicious risk, on the one hand the excessive use of attenuated vaccine has virulence and returns strong risk, another party Face may cause the recombination variation of popular strain and vaccine strain and make field viral prevalence situation increasingly complexization, and make above-mentioned The purification difficulty of several diseases further increases, so the research and development application of novel subunit vaccine is for ensureing animal and veterinary industry Sustainable and healthy development it is most important.
Summary of the invention
Based on above-mentioned discovery and understanding, the main purpose of the present invention is to provide a kind of pig epidemic diarrheas, pig transmissible Sick three subunit vaccines of gastroenteritis, pig fourth type coronavirus, antigenic component are Porcine epidemic diarrhea virus, pig transmissible stomach and intestine The respective antigen protein S1 of three kinds of viruses such as scorching virus and pig fourth type coronavirus, and three kinds of viral S1 protein contents need to divide Not >=150 μ g/ml(part).
Preferably, the S1 albumen of Porcine epidemic diarrhea virus of the invention, 1 albumen of pig infectious gastroenteritis virus S and pig The mass ratio of the S1 albumen of fourth type coronavirus is 1:1:1.
Wherein the amino acid sequence of Porcine epidemic diarrhea virus S1 albumen is SEQ ID NO:1, expresses pig epidemic diarrhea The Pichia Pastoris X33-PEDV-S1(Pichia pastoris X33-PEDV S1 of viral S1 albumen), in It is preserved in China General Microbiological culture presevation administrative center on June 30th, 2017, deposit number is CGMCC NO:14372, is protected Hiding address is Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, Institute of Microorganism, Academia Sinica.
Wherein the amino acid sequence of 1 albumen of pig infectious gastroenteritis virus S is SEQ ID NO:2, expresses pig transmissible stomach The Pichia Pastoris X33-TGEV-S1(Pichia pastoris X33-TGEV S1 of enteritis virus S1 albumen), China General Microbiological culture presevation administrative center is preserved on June 30th, 2017, deposit number is CGMCC NO:14371, Preservation address is Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, Institute of Microorganism, Academia Sinica.
Wherein the amino acid sequence of pig fourth type coronavirus S1 albumen is SEQ ID NO:3, expresses pig fourth type coronavirus The Pichia Pastoris X33-PDCoV-S1(Pichia pastoris X33-PDCoV S1 of S1 albumen), in 2017 It is preserved in China General Microbiological culture presevation administrative center on June 30, deposit number is CGMCC NO:14370, preservation Location is Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, Institute of Microorganism, Academia Sinica.
The vaccine adjuvant is MF59 adjuvant.
Porcine epidemic diarrhea virus S1 protein content >=g/ml(parts of 150 μ in above-mentioned triple vaccine), pig transmissible The S1 protein content of marcy agent >=g/ml(parts of 150 μ), S1 protein content >=150 μ g/ml of pig fourth type coronavirus (head part).
The sick three subunit vaccines peace of pig epidemic diarrhea of the invention, transmissible gastroenteritis of swine, pig fourth type coronavirus Quan Xinggao, immunogenicity is good, it is immune after antibody generate quickly and hold time length compared with antibody titers, vaccine long shelf-life is exempted from Epidemic disease dosage is small, and the adjuvant of selection is easy to inject, can a needle prevent and treat three kinds of main diarrhea related diseases viral diseases, improve depositing for piglet Motility rate.
Detailed description of the invention
Fig. 1 is Porcine epidemic diarrhea virus S1 of embodiment of the present invention protein gene, 1 albumen of pig infectious gastroenteritis virus S The amplification qualification figure of gene and the PCR of pig fourth type coronavirus disease S1 protein gene,
Fig. 2 is that the blast of Porcine epidemic diarrhea virus S1 albumen of the invention compares figure;
Fig. 3 is the Phylogenetic tree schematic diagram of Porcine epidemic diarrhea virus S1 albumen of the invention;
Fig. 4 is that 1 albumen blast of pig infectious gastroenteritis virus S of the invention compares figure;
Fig. 5 is the Phylogenetic tree schematic diagram of 1 albumen of pig infectious gastroenteritis virus S of the invention;
Fig. 6 is that the blast of pig fourth type coronavirus S1 albumen of the invention compares figure;
Fig. 7 is the Phylogenetic tree schematic diagram of pig fourth type coronavirus S1 albumen of the invention;
Fig. 8 is recombinant bacterium fermentation inducement expression product SDS-PAGE electrophoresis detection figure of the embodiment of the present invention.
Specific embodiment
The embodiment of the present invention is specifically described with reference to the accompanying drawing
Embodiment 1: Porcine epidemic diarrhea virus (PEDV) S1 gene, transmissible gastro-enteritis virus (TGEV) S1 gene with The screening of pig fourth type coronavirus (PDCoV) S1 gene
From 2010, there is the grice diarrhoea state of an illness of large area in the multiple province ,city and areas in China's Mainland, and site morbidity pig Commercially available diarrhea vaccine at that time has been injected before, therefore has speculated that Field epidemic virus is strain after variation, to 2013- After clinical sample detection between 2016, different Porcine epidemic diarrhea virus, pig transmissible stomach are isolated out of morbid pig body Enteritis virus and pig fourth type coronavirus, after carrying out genome sequencing and phylogenetic analysis (Fig. 3, Fig. 5 and Fig. 7), Selected PEDV KB2013-4 plants, BD plants of TGEV and SD plants of the PDCoV Reference Strains as current Field epidemic strain;Wherein KB2013-4 plants of PEDV (Porcine epidemic diarrhea virus Porcine epidemic diarrhea virus) is in 2016 It is preserved within 23 days 08 month China General Microbiological culture presevation administrative center, deposit number is CGMCC NO:12663, preservation Location is Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, Institute of Microorganism, Academia Sinica;BD plants of (pig transmissible stomaches of TGEV Enteritis virus Transmissible Gastroenteritis virus) be preserved on 06 07th, 2017 China it is general Logical Microbiological Culture Collection administrative center, deposit number are CGMCC NO:13856, and preservation address is the Chaoyang District, Beijing City North Star The institute 3 of West Road 1, Institute of Microorganism, Academia Sinica;SD plants of PDCoV (pig δ coronavirus Porcine Deltacoronavirus it) was preserved in China General Microbiological culture presevation administrative center on 06 07th, 2017, is protected Hiding number is CGMCC NO:13853, and preservation address is Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, the micro- life of the Chinese Academy of Sciences Object research institute.
According to the antigenic characteristic and amino acid sequence of Porcine epidemic diarrhea virus S1 albumen, design synthesizes pair of primers, The site primer 1:5 '-GGATCCATGAAGTCTTTAACCTACTT-3 ', HI containing Bam;Primer 2: 5'- The site AAGCTTAACACCTTCAAGTGGTTTAG-3 ', III containing Hind;Take PEDV KB2013-4 strain virus gene as mould Plate, PCR amplification target fragment (the amplification qualification figure that Fig. 1 is Porcine epidemic diarrhea virus S1 gene PCR), product recycling connection PEASY-T1 cloning vector, conversion and screening positive clone pEASY-T1-PEDV-S1, through sequencing;Its nucleotides sequence is classified as SEQ ID NO:4, the sequence of the albumen of coding are SEQ ID NO:1.The popular pig between 2010-2017 disclosed in NCBI Epidemic diarrhea virus S1 protein sequence is compared, homology between 96.5%-99.9% (Fig. 2).
According to the antigenic characteristic and amino acid sequence of 1 albumen of pig infectious gastroenteritis virus S, design synthesizes pair of primers, The site primer 3:5 '-GGATCCATGAAAAAACTATTTGTG-3 ', HI containing Bam;Primer 4: 5'- The site AAGCTTACCAACAGGACTCAACGAC-3 ', III containing Hind;Take TGEV BD strain virus gene as template, PCR expands Increase target fragment (the amplification qualification figure that Fig. 1 is 1 gene PCR of pig infectious gastroenteritis virus S), product recycling connection pEASY-T1 Cloning vector, conversion and screening positive clone pEASY-T1-TGEV-S1, through sequencing;Its nucleotides sequence is classified as SEQ ID NO:5, the sequence of the albumen of coding are SEQ ID NO:2.The popular pig transmissible between 2010-2017 disclosed in NCBI 1 protein sequence of gastroenteritis virus S is compared, homology between 96.7%-99.9% (Fig. 4).
According to the antigenic characteristic and amino acid sequence of pig fourth type coronavirus S1 albumen, design synthesizes pair of primers, The site primer 5:5 '-GGATCCATGCAGAGAGCTCTATTGAT-3 ', HI containing Bam;Primer 6: 5'- The site AAGCTTACCATCACTACACACGCTGAT-3 ', III containing Hind;Take PDCoV SD strain virus gene as template, PCR amplification target fragment (the amplification qualification figure that Fig. 1 is pig fourth type coronavirus S1 gene PCR), product recycling connection pEASY- T1 cloning vector, conversion and screening positive clone pEASY-T1-PDCoV-S1, through sequencing;Its nucleotides sequence is classified as SEQ ID NO:6, the sequence of the albumen of coding are SEQ ID NO:3.The popular pig fourth type between 2013-2017 disclosed in NCBI Coronavirus S1 protein sequence is compared, homology between 96.8%-99.9% (Fig. 6).
Embodiment 2: recombination Porcine epidemic diarrhea virus S1 albumen, 1 albumen of pig infectious gastroenteritis virus S and pig fourth type are preced with The preparation of shape virus S1 albumen,
The following steps are included: a. construction of expression vector;B. building expression bacterial strain;C. Porcine epidemic diarrhea virus S1 egg is recombinated The induction of white, 1 albumen of pig infectious gastroenteritis virus S and pig fourth type coronavirus S1 albumen and extraction purification.It is specific as follows: will Positive colony plasmid pEASY-T1-PEDV-S1 or pEASY-T1-TGEV-S1 or pEASY-T1-PDCoV-S1 and expression vector PPICZ α carrier uses Bam HI and Hind III double enzyme digestion product after 1.0% agarose gel electrophoresis respectively, is returned with DNA gel Kits recycling is received, obtains 1.9 kb or 1.9 kb or 1.6 kb and 3.3 kb segments respectively, connects structure in 16 DEG C of orientations PPICZ α-PEDV-S1 or pPICZ α-TGEV-S1 or pPICZ α-PDCoV-S1 expression vector is built, after digestion identification is correct; After plasmid linearization, electrotransformation enters Pichia pastoris competent cell, construct Pichiapastoris expression strain X33-PEDV-S1 or X33- TGEV-S1 or X33- PDCoV-S1, and extract expression strain X 33- PEDV-S1 or X33- TGEV-S1 or X33- PDCoV-S1 genome carries out PCR identification correctly using primer primer 1/2 or primer3/4 or primer5/6 respectively, in On June 30th, 2017 is preserved in China General Microbiological culture presevation administrative center, and deposit number is respectively CGMCC No.14370;Carry out inducing expression, monoclonal of the picking containing X33-PEDV-S1 or X33- TGEV-S1 or X33- PDCoV-S1 Colony inoculation is stayed overnight in BMGY fluid nutrient medium, 30 DEG C of shaken cultivations, and thalline were collected by centrifugation, after being suspended with suitable BMMY, adds Enter 0.55% methanol, 30 DEG C induce 96 hours.4 DEG C, 9000rpm is centrifuged 5min, retains supernatant, 40% ammonium sulfate precipitation is added Afterwards, 12000rpm is centrifuged 5min and collects albumen precipitation, with the molten albumen of PBS weight.Protein electrophoresis sample-loading buffer, boiling water boiling 8 is added After minute, carrying out SDS-PAGE identification with 12% separation gel, (Fig. 8 is the SDS- PAGE electricity of recombinant bacterium fermentation inducement expression product It swims rating diagram, 1,2,3 be respectively PEDV-S1, TGEV-S1 and PDCoV-S1 protein expressioning products precipitating in figure, and M are molecular weight mark Quasi- protein).
China is preserved in by X33-PEDV-S1 plants of Pichiapastoris expression strain that produce Porcine epidemic diarrhea virus S1 albumen General Microbiological Culture preservation administrative center, deposit number are CGMCC No.14372.
X33-TGEV-S1 plants of Pichiapastoris expression strain of 1 albumen of pig infectious gastroenteritis virus S will be produced to be preserved in State's General Microbiological Culture preservation administrative center, deposit number are CGMCC No.14371.
China is preserved in by X33-PDCoV-S1 plants of Pichiapastoris expression strain that produce pig fourth type coronavirus S1 albumen General Microbiological Culture preservation administrative center, deposit number are CGMCC No.14370.
1. X33-PEDV-S1 or X33- TGEV-S1 or X33- PDCoV-S1 strain is inoculated with by the preparation of seedling bacterium solution In the YPD fluid nutrient medium containing bleomycin, 30 DEG C shaken cultivation 16-18 hours.Then streak inoculation is in mould added with rich Lay The YPD solid medium of element is chosen colonies typical 2-3 and is mixed in a small amount of YPD fluid nutrient medium, sets in 30 DEG C of shaking tables and vibrate Culture 18 hours, quantitative separating, after purely examining, as first order seed.First order seed is taken to be inoculated in BMGY fluid nutrient medium In, 30 DEG C shaken cultivation 16-18 hours, after microscopy, 2-8 DEG C of preservation is set, as secondary seed.
2. the incomplete fluid nutrient medium of BMGY is added by fermenter volume 60% (V/V) in the preparation of seedling albumen, press simultaneously Defoaming agent is added in culture medium 0.1% (V/V), is passed through high-temp steam sterilizing 30 minutes, is down to 32 DEG C to culture medium temperature, YNB is added And biotin, it is inoculated with production Pichia pastoris X33-PEDV-S1 or X33- TGEV-S1 or X33- PDCoV-S1 secondary seed Liquid, fermentor parameter setting are respectively mixing speed 800r/min, 30 DEG C of temperature, maintain D0 value (dissolved oxygen amount) 20%.Culture 24 Bacterium solution after hour adds methanol, and the speed of adding of methanol is the culture of 2ml/h/L inducing expression, according to the above ferment control parameter And technique inducing expression 120 hours;Fermented and cultured bacterium solution through tube centrifuge 10000r/min be centrifuged 30 minutes, harvest it is upper Clearly, after ammonium sulfate precipitated protein being added, 30 minutes harvest precipitatings is centrifuged by 12000r/min, suitable physiological saline solution is added Albumen precipitation.
3. protein liquid is placed in inactivation bottle by inactivation, metered 10% formalin is mixed them thoroughly with adding with shaking, The ultimate density of formalin is 0.1%.It is poured into another inactivation bottle after adding formalin, the disease nearby adhered to avoid bottleneck Poison fails to contact inactivator.37 DEG C inactivation 16 hours after take out, set 2-8 DEG C of preservation.
4. the inspection of semifinished product
4.1 steriling tests carry out steriling test by existing " Chinese veterinary pharmacopoeia " annex.
4.2 determining the protein quantity detect protein content by Bradford method.
4.3 inactivations, which are examined, takes a small amount of inoculation YPD solid medium for the protein liquid after inactivation, sets 30 DEG C and continues culture 72 Hour.Sterile length of being born is observed, inactivation is sentenced and examines qualification.
Embodiment 3: sick three subunit vaccines of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus Preparation
Vaccine preparation is carried out by semi-finished product PEDV-S1, TGEV-S1 and PDCoV-S1 proteantigen after the assay was approved (each liquid component is counted by volume in following preparation).
The Arlacel-85 of 0.5% volume is dispersed in the squalene phase of 5% volume by the preparation of 1 adjuvant, the tween-with 0.5% volume 80 are mixed into the 10mM sodium citrate buffer solution of 94% volume, and then mixed at high speed obtains thick lotion.Then by this thick lotion High pressure homogenizer (1200bar, 6-8 circulations) is iterated through, the lotion with uniform droplet size is generated;Lotion is filtered 0.22 μm of filter membrane, to remove larger oil droplet, obtain lotion average droplet size kept at 4 DEG C at least 3 years it is constant.
Porcine epidemic diarrhea virus S1 albumen, 1 albumen of pig infectious gastroenteritis virus S and pig fourth type are preced with by the preparation of 2 antigens Shape virus S1 albumen uses normal saline dilution at 150 μ g/0.1ml respectively.
3 emulsifications take 1 part of oily phase to be put in 50L-200L high-speed shearing machine, start the stirring of four leaf paddle slow rotations, while Xu Xu is added 1 part of water phase, with 300-500r/min, emulsifies 5 minutes.After emulsification, 10mL vaccine is taken to be centrifuged 15 points with 3000r/min Clock, the water phase that tube bottom is precipitated should be no more than 0.5ml.
4 vaccine product inspections
4.1 character
Appearance vaccine should be milky emulsion, free from admixture and qualification is answered in outer packing.
Dosage form is oil-in-water type.A cleaning suction pipe is taken, a small amount of vaccine is drawn and instills in cold water, it is uniform after shaking gently It is dispersed in water.
Stability is drawn vaccine 10ml and is added in centrifuge tube, and with 3000r/min centrifugation 15 minutes, the water phase that tube bottom is precipitated was answered No more than 0.5ml.
Viscosity is carried out by existing " Chinese veterinary pharmacopoeia " annex, should meet regulation.
4.2 loading quantity inspections are carried out by existing " Chinese veterinary pharmacopoeia " annex, should meet regulation.
4.3 steriling tests are carried out by existing " Chinese veterinary pharmacopoeia " annex, should meet regulation.
With 3-5 age in days piglet 10, (corresponding sow should be later stage of pregnancy detection pig epidemic diarrhea, passes 4.4 safety verifications Metachromia gastroenteritis and pig fourth type coronavirus disease neutralize antibody titers≤1:4), neck intramuscular injection vaccine 1.0ml after every ear, Control 5 is set simultaneously, is raised, is observed continuously 14 at identical conditions, the feeding of record test pig, drinking-water and clinical setting. Any locally and systemically adverse reaction as caused by vaccine should not occur.
4.5 efficacy test
4.5.1 the immune piglet serum neutralizing antibody of inspection is inoculated with the piglet of 1 times of immunizing dose, uses within 2 weeks after immune and neutralizes Antibody test method examines the serum for Porcine epidemic diarrhea virus, transmissible gastro-enteritis virus and pig fourth type coronavirus disease Neutralizing antibody, 10 piglets at least should turn sun by 8 piglets, for three kinds of viral neutralize antibody titers >=1:32, can reach Good immune effect;
4.5.2 piglet immunological agent 15 that Immunization test 1 multiple dose of inoculation is done to piglet, are divided into for 3 weeks after immune 3 groups (5/group), together with the piglet of the same age 15 (being also classified into 3 groups, 5/group) of non-vaccine inoculation, with 105.0 TCID50/ ml pig Epidemic diarrhea virus, transmissible gastro-enteritis virus and the virulent oral challenge respectively of pig fourth type coronavirus disease, exempt from after attacking poison Epidemic disease piglet should have 4/5 protection respectively, and the morbidity of control pig 5/5 or immune piglet 5/5 are protected, and control piglet 4/5 falls ill, and be judged to exempt from Epidemic disease is qualified.
4.6 residual formaldehydes detect the testing result of 3 batches of three subunit vaccines be respectively 0.092%, 0.085%, 0.086%, it is below the regulation (0.2%) of veterinary biologics general rule.
Pig epidemic diarrhea, the transmissible gastroenteritis of swine, pig fourth type coronavirus disease three manufactured experimently in embodiment 4, embodiment 3 Connection subunit vaccine is with the serum neutralizing antibody of commercially available inactivated vaccine and attenuated live vaccines compared with immune protective effect
Sick three subunits of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus in 1 materials Example 3 Vaccine preproduction;Transmissible gastroenteritis of swine, pig epidemic diarrhea, porcine rotavirus (G5 type) trigeminal live vaccine (the weak magnificent strain of poison+ CV777 plants+NX plants of weak poison), Jilin decent job biological products limited liability company produces (lot number 2016006);Pig transmissible stomach and intestine Scorching, pig epidemic diarrhea bivalent inactivated vaccine, Jilin decent job biological products limited liability company produce (lot number 2016003).
2 methods
The design of 2.1 animal experiments
With 3-5 age in days piglet 65 (corresponding sow should be later stage of pregnancy detection pig epidemic diarrhea, transmissible gastroenteritis and Pig fourth type coronavirus disease neutralize antibody titers≤1:4), neck intramuscular injection vaccine 1.0ml after every ear, while setting control 15 Only, raise, be observed continuously 14 at identical conditions, the feeding of record test pig, drinking-water and clinical setting, after 14d respectively into Row blood sampling, and strong virus attack was used in the blood sampling same day.15 of negative control group are not immunized, and are divided into 3 groups, are respectively used to three kinds of diseases Poison attacks the negative control of poison.Three vaccine groups are respectively equipped with one group of (5) blank control group, only immune without attacking poison.Specifically Grouping situation is shown in Table 1.
1 animal experiment of table is grouped situation
2.2 potency test
2.2.1 antibody determination
Efficacy test is carried out referring to the 4.5.1 item method in embodiment 3, is taken a blood sample respectively to immune latter 14 days piglets, point From serum, measurement is directed to the neutralization of Porcine epidemic diarrhea virus, transmissible gastro-enteritis virus and pig fourth type coronavirus respectively Antibody titer.
2.2.2 Immunization is protected
Efficacy test is carried out referring to the 4.5.2 item method applied in example 3, immune latter 14 days piglets are used respectively corresponding strong Poison is attacked.It is observed continuously 10, records the incidence of each group piglet.
3 results
3.1 antibody determination results
With sick three subunit vaccines of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus in embodiment 3 Preproduction, transmissible gastroenteritis of swine, pig epidemic diarrhea, porcine rotavirus (G5 type) trigeminal live vaccine (weak magnificent strain+weak poison of poison CV777 plants+NX plants) (lot number 2016006) and transmissible gastroenteritis of swine, pig epidemic diarrhea bivalent inactivated vaccine (lot number 2016003) the susceptible piglet of 3~5 ages in days health is immunized respectively, the neutralizing antibody after 14d the results are shown in Table 2.The result shows that Porcine epidemic diarrhea virus, transmissible gastro-enteritis virus and pig fourth type are directed to after three subunit vaccines are immune in piglet serum The neutralize antibody titers of coronavirus are not less than 1:32, and commercially available bivalent inactivated vaccine and commercially available three attenuated live vaccines are immune The neutralize antibody titers of piglet are not higher than 1:16.Therefore, generated after three subunit vaccines are immune for 3 kinds it is viral in It is better than commercially available three attenuated live vaccines and commercially available bivalent inactivated vaccine with antibody level.
After 2 three subunit vaccine preproduction of table and commercially available three attenuated live vaccines, commercially available bivalent inactivated vaccine are immune Neutralize antibody titers compare
3.2 Immunizations protect result
With sick three subunit vaccines of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus in embodiment 3 Preproduction, transmissible gastroenteritis of swine, pig epidemic diarrhea, porcine rotavirus (G5 type) trigeminal live vaccine (weak magnificent strain+weak poison of poison CV777 plants+NX plants) (lot number 2016006) and transmissible gastroenteritis of swine, pig epidemic diarrhea bivalent inactivated vaccine (lot number 2016003) the susceptible piglet of 3~5 ages in days health is immunized respectively, after 14d respectively with it is corresponding it is virulent attacked, continuously Observation 10 days, that attacks poison protection the results are shown in Table 3.
After 3 three subunit vaccine preproduction of table and commercially available three attenuated live vaccines, commercially available bivalent inactivated vaccine are immune Malicious protecting effect is attacked to compare
The result shows that pig epidemic diarrhea of the invention, transmissible gastroenteritis of swine, pig fourth type coronavirus disease three are sub- single Position vaccine safety is high, and immunogenicity is good, it is immune after antibody generate quickly and hold time length compared with antibody titers, vaccine saves Phase is long, and immunizing dose is small, and the adjuvant of selection is easy to inject, can a needle prevent and treat three kinds of main diarrhea related diseases viral diseases, raising The survival rate of piglet.
Sequence table
<110>Shaanxi Nowe Li Hua Biotechnology Co., Ltd
<120>sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus
<130> 2017-11-08
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 638
<212> PRT
<213>artificial synthesized (Porcine epidemic diarrhea virus)
<400> 1
Met Lys Ser Leu Thr Tyr Phe Trp Leu Phe Leu Pro Val Leu Ser Thr
1 5 10 15
Leu Ser Leu Pro Gln Asp Val Thr Arg Cys Ser Ala Asn Thr Asn Phe
20 25 30
Arg Arg Phe Phe Ser Lys Phe Asn Val Gln Ala Pro Ala Val Val Val
35 40 45
Leu Gly Gly Tyr Leu Pro Ile Gly Glu Asn Gln Gly Val Asn Ser Thr
50 55 60
Trp Tyr Cys Ala Gly Gln His Pro Thr Ala Ser Gly Val His Gly Ile
65 70 75 80
Phe Val Ser His Ile Arg Gly Gly His Gly Phe Glu Ile Gly Ile Ser
85 90 95
Gln Glu Pro Phe Asp Pro Ser Gly Tyr Gln Leu Tyr Leu His Lys Ala
100 105 110
Thr Asn Gly Asn Thr Asn Ala Thr Ala Arg Leu Arg Ile Cys Gln Phe
115 120 125
Pro Ser Ile Lys Thr Leu Gly Pro Thr Ala Asn Asn Asp Val Thr Thr
130 135 140
Gly Arg Asn Cys Leu Phe Asn Lys Ala Ile Pro Ala His Met Ser Glu
145 150 155 160
His Ser Val Val Gly Ile Thr Trp Asp Asn Asp Arg Val Thr Val Phe
165 170 175
Ser Asp Lys Ile Tyr Tyr Phe Tyr Phe Lys Asn Asp Trp Ser Arg Val
180 185 190
Ala Thr Lys Cys Tyr Asn Ser Gly Gly Cys Ala Met Gln Tyr Val Tyr
195 200 205
Glu Pro Thr Tyr Tyr Met Leu Asn Val Thr Ser Ala Gly Glu Asp Gly
210 215 220
Ile Ser Tyr Gln Pro Cys Thr Ala Asn Cys Ile Gly Tyr Ser Ala Asn
225 230 235 240
Val Phe Ala Thr Glu Pro Asn Gly His Ile Pro Glu Gly Phe Ser Phe
245 250 255
Asn Asn Trp Phe Leu Leu Ser Asn Asp Ser Thr Leu Val His Gly Lys
260 265 270
Val Val Ser Asn Gln Pro Leu Leu Val Asn Cys Leu Leu Ala Ile Pro
275 280 285
Lys Ile Tyr Gly Leu Gly Gln Phe Phe Ser Phe Asn Gln Thr Ile Asp
290 295 300
Gly Val Cys Asn Gly Ala Ala Val Gln Arg Ala Pro Glu Ala Leu Arg
305 310 315 320
Phe Asn Ile Asn Asp Thr Ser Val Ile Leu Ala Glu Gly Ser Ile Val
325 330 335
Leu His Thr Ala Leu Gly Thr Asn Phe Ser Phe Val Cys Ser Asn Ser
340 345 350
Ser Asp Pro His Leu Ala Thr Phe Ala Ile Pro Leu Gly Ala Ile Gln
355 360 365
Val Pro Tyr Tyr Cys Phe Leu Lys Val Asp Thr Tyr Asn Ser Thr Val
370 375 380
Tyr Lys Phe Leu Ser Val Leu Pro Pro Thr Val Arg Glu Ile Val Ile
385 390 395 400
Thr Lys Tyr Gly Asp Val Tyr Val Asn Gly Phe Gly Tyr Leu His Leu
405 410 415
Gly Leu Leu Asp Ala Val Thr Ile Asn Phe Thr Gly His Gly Thr Asp
420 425 430
Asp Asp Val Ser Gly Phe Trp Thr Ile Ala Ser Thr Asn Phe Val Asp
435 440 445
Ala Leu Ile Glu Val Gln Gly Thr Ala Ile Gln Arg Ile Leu Tyr Cys
450 455 460
Asp Asp Pro Val Ser Gln Leu Lys Cys Ser Gln Val Ala Phe Asp Leu
465 470 475 480
Asp Asp Gly Phe Tyr Pro Ile Ser Ser Arg Asn Leu Leu Ser His Glu
485 490 495
Gln Pro Ile Ser Phe Val Ala Leu Pro Ser Phe Asn Asp His Ser Phe
500 505 510
Val Asn Ile Thr Val Ser Ala Ser Phe Gly Gly His Ser Gly Ala Asn
515 520 525
Leu Ile Ala Ser Asp Thr Thr Ile Asn Gly Phe Ser Ser Phe Cys Val
530 535 540
Asp Thr Arg Gln Phe Thr Ile Ser Leu Phe Tyr Asn Val Thr Asn Ser
545 550 555 560
Tyr Gly Tyr Val Ser Lys Ser Gln Asp Ser Asn Cys Pro Phe Thr Leu
565 570 575
Gln Ser Val Asn Asp Tyr Leu Ser Phe Ser Lys Phe Cys Val Ser Thr
580 585 590
Ser Leu Leu Ala Ser Ala Cys Thr Ile Asp Leu Phe Gly Tyr Pro Glu
595 600 605
Phe Gly Ser Gly Val Lys Phe Thr Ser Leu Tyr Phe Gln Phe Thr Lys
610 615 620
Gly Glu Leu Ile Thr Gly Thr Ser Lys Pro Leu Glu Gly Val
625 630 635
<210> 2
<211> 632
<212> PRT
<213>artificial synthesized (transmissible gastro-enteritis virus)
<400> 2
Met Lys Lys Leu Phe Val Val Leu Val Val Met Pro Leu Ile Tyr Gly
1 5 10 15
Asp Asn Phe Pro Cys Ser Lys Leu Thr Asn Arg Thr Ile Gly Asn Gln
20 25 30
Trp Asn Leu Ile Glu Thr Phe Leu Leu Asn Tyr Ser Ser Arg Leu Pro
35 40 45
Pro Asn Ser Asp Val Val Leu Gly Asp Tyr Phe Pro Thr Val Gln Pro
50 55 60
Trp Phe Asn Cys Ile Arg Asn Asp Ser Asn Asp Leu Tyr Val Thr Leu
65 70 75 80
Glu Asn Leu Lys Ala Leu Tyr Trp Asp Tyr Ala Thr Glu Asn Ile Thr
85 90 95
Trp Asn His Arg Gln Arg Leu Asn Val Val Val Asn Gly Tyr Pro Tyr
100 105 110
Ser Ile Thr Val Thr Thr Thr Arg Asn Phe Asn Ser Ala Glu Gly Ala
115 120 125
Ile Ile Cys Ile Cys Lys Gly Ser Pro Pro Thr Thr Thr Thr Glu Ser
130 135 140
Ser Leu Thr Cys Asn Trp Gly Ser Glu Cys Arg Leu Asn His Lys Phe
145 150 155 160
Pro Ile Cys Pro Ser Asn Ser Glu Ala Asn Cys Gly Asn Met Leu Tyr
165 170 175
Gly Leu Gln Trp Phe Ala Asp Glu Val Val Ala Tyr Leu His Gly Ala
180 185 190
Ser Tyr Arg Ile Ser Phe Glu Asn Gln Trp Ser Gly Thr Val Thr Phe
195 200 205
Gly Asp Met Arg Ala Thr Thr Leu Glu Val Ala Gly Thr Leu Val Asp
210 215 220
Leu Trp Trp Phe Asn Pro Val Tyr Asp Val Ser Tyr Tyr Arg Val Asn
225 230 235 240
Asn Lys Asn Gly Thr Thr Val Val Ser Asn Cys Thr Asp Gln Cys Ala
245 250 255
Ser Tyr Val Ala Asn Val Phe Thr Thr Gln Pro Gly Gly Phe Ile Pro
260 265 270
Ser Asp Phe Ser Phe Asn Asn Trp Phe Leu Leu Thr Asn Ser Ser Thr
275 280 285
Leu Val Ser Gly Lys Leu Val Thr Lys Gln Pro Leu Leu Val Asn Cys
290 295 300
Leu Trp Pro Val Pro Ser Phe Glu Glu Ala Ala Ser Thr Phe Cys Phe
305 310 315 320
Glu Gly Ala Gly Phe Asp Gln Cys Asn Gly Ala Val Leu Asn Asn Thr
325 330 335
Val Asp Val Ile Arg Phe Asn Leu Asn Phe Thr Thr Asn Val Gln Ser
340 345 350
Gly Lys Gly Ala Thr Val Phe Ser Leu Asn Thr Thr Gly Gly Val Thr
355 360 365
Leu Glu Ile Ser Cys Tyr Thr Val Ser Asp Ser Ser Phe Phe Ser Tyr
370 375 380
Gly Glu Ile Pro Phe Gly Val Thr Asp Gly Pro Arg Tyr Cys Tyr Val
385 390 395 400
His Tyr Asn Gly Thr Ala Leu Lys Tyr Leu Gly Thr Leu Pro Pro Ser
405 410 415
Val Lys Glu Ile Ala Ile Ser Lys Trp Gly His Phe Tyr Ile Asn Gly
420 425 430
Tyr Asn Phe Phe Ser Thr Phe Pro Ile Asp Cys Ile Ser Phe Asn Leu
435 440 445
Thr Thr Gly Asp Ser Asp Val Phe Trp Thr Ile Ala Tyr Thr Ser Tyr
450 455 460
Thr Glu Ala Leu Val Gln Val Glu Asn Thr Ala Ile Thr Lys Val Thr
465 470 475 480
Tyr Cys Asn Ser His Val Asn Asn Ile Lys Cys Ser Gln Ile Thr Ala
485 490 495
Asn Leu Asn Asn Gly Phe Tyr Pro Val Ser Ser Ser Glu Val Gly Leu
500 505 510
Val Asn Lys Ser Val Val Leu Leu Pro Ser Phe Tyr Thr His Thr Ile
515 520 525
Val Asn Ile Thr Ile Gly Leu Gly Met Lys Arg Ser Gly Tyr Gly Gln
530 535 540
Pro Ile Ala Ser Thr Leu Ser Asn Ile Thr Leu Pro Met Gln Asp His
545 550 555 560
Asn Thr Asp Val Tyr Cys Ile Arg Ser Asp Gln Phe Ser Val Tyr Val
565 570 575
His Ser Thr Cys Lys Ser Ala Leu Trp Asp Asn Ile Phe Lys Arg Asn
580 585 590
Cys Thr Asp Val Leu Asp Ala Thr Ala Val Ile Lys Thr Gly Thr Cys
595 600 605
Pro Phe Ser Phe Asp Lys Leu Asn Asn Tyr Leu Thr Phe Asn Lys Phe
610 615 620
Cys Leu Ser Leu Ser Pro Val Gly
625 630
<210> 3
<211> 546
<212> PRT
<213>artificial synthesized (pig fourth type coronavirus)
<400> 3
Met Gln Arg Ala Leu Leu Ile Met Thr Leu Leu Cys Leu Val Arg Ala
1 5 10 15
Lys Phe Ala Asp Asp Leu Leu Asp Leu Leu Thr Phe Pro Gly Ala His
20 25 30
Arg Phe Leu His Lys Leu Thr Ser Asn Ser Ser Ser Phe Tyr Ser Arg
35 40 45
Ala Asn Asn Phe Asp Val Gly Val Leu Pro Gly Tyr Pro Thr Glu Asn
50 55 60
Val Asn Leu Phe Ser Pro Leu Thr Asn Ser Thr Leu Pro Ile Asn Gly
65 70 75 80
Leu His Arg Ser Tyr Gln Pro Leu Met Leu Asn Cys Leu Thr Lys Ile
85 90 95
Thr Asn Thr Leu Ser Met Tyr Leu Leu Pro Ser Glu Ile Gln Thr Tyr
100 105 110
Ser Cys Gly Gly Ala Met Val Lys Tyr Gln Thr His Asp Ala Val Arg
115 120 125
Ile Ile Leu Asp Leu Thr Val Thr Asp His Ile Ser Val Glu Val Val
130 135 140
Gly Gln Arg Gly Glu Asn Tyr Val Phe Val Cys Ser Glu Gln Phe Asn
145 150 155 160
Tyr Thr Thr Ala Leu His Asn Ser Thr Phe Phe Ser Leu Asn Ser Glu
165 170 175
Leu Tyr Cys Phe Thr Asn Asn Thr Tyr Leu Gly Ile Leu Pro Pro Asp
180 185 190
Leu Thr Asp Phe Thr Val Tyr Arg Thr Gly Gln Phe Tyr Ala Asn Gly
195 200 205
Tyr Leu Leu Gly Thr Leu Pro Ile Thr Val Asn Tyr Val Arg Leu Tyr
210 215 220
Arg Gly His Leu Ser Ala Asn Ser Ala His Phe Ala Leu Ala Asn Leu
225 230 235 240
Thr Asp Thr Leu Ile Thr Leu Thr Asn Thr Thr Ile Ser Gln Ile Thr
245 250 255
Tyr Cys Asp Lys Ser Val Val Asp Ser Ile Ala Cys Gln Arg Ser Ser
260 265 270
His Glu Val Glu Asp Gly Phe Tyr Ser Asp Pro Lys Ser Ala Val Arg
275 280 285
Ala Arg Gln Arg Thr Ile Val Thr Leu Pro Lys Leu Pro Glu Leu Glu
290 295 300
Val Val Gln Leu Asn Ile Ser Ala His Met Asp Phe Gly Glu Ala Arg
305 310 315 320
Leu Asp Ser Val Thr Ile Asn Gly Asn Thr Ser Tyr Cys Ala Thr Lys
325 330 335
Pro Tyr Phe Arg Leu Glu Thr Asn Phe Met Cys Thr Gly Cys Thr Met
340 345 350
Asn Leu Arg Thr Asp Thr Cys Ser Phe Asp Leu Ser Ala Val Asn Asn
355 360 365
Gly Met Ser Phe Ser Gln Phe Cys Leu Ser Thr Glu Ser Gly Ala Cys
370 375 380
Glu Met Lys Ile Ile Val Thr Tyr Val Trp Asn Tyr Leu Leu Arg Gln
385 390 395 400
Arg Leu Tyr Val Thr Ala Val Glu Gly Gln Thr His Thr Gly Thr Thr
405 410 415
Ser Val His Ala Thr Asp Thr Ser Ser Val Ile Thr Asp Val Cys Thr
420 425 430
Asp Tyr Thr Ile Tyr Gly Val Ser Gly Thr Gly Ile Ile Lys Pro Ser
435 440 445
Asp Leu Leu Leu His Asn Gly Ile Ala Phe Thr Ser Pro Thr Gly Glu
450 455 460
Leu Tyr Ala Phe Lys Asn Ile Thr Thr Gly Lys Thr Leu Gln Val Leu
465 470 475 480
Pro Cys Glu Thr Pro Ser Gln Leu Ile Val Ile Asn Asn Thr Val Val
485 490 495
Gly Ala Ile Thr Ser Ser Asn Ser Thr Glu Asn Asn Arg Phe Thr Thr
500 505 510
Thr Ile Val Thr Pro Thr Phe Phe Tyr Ser Thr Asn Ala Thr Thr Phe
515 520 525
Asn Cys Thr Lys Pro Val Leu Ser Tyr Gly Pro Ile Ser Val Cys Ser
530 535 540
Asp Gly
545
<210> 4
<211> 1914
<212> DNA
<213>artificial synthesized (Porcine epidemic diarrhea virus)
<400> 4
atgaagtctt taacctactt ctggttgttc ttaccagtac tttcaacact tagcctacca 60
caagatgtca ccaggtgctc agctaacact aattttaggc ggttcttttc aaaatttaat 120
gttcaggcgc ctgcagttgt tgtactgggc ggttatctac ctattggtga aaaccagggt 180
gtcaattcaa cttggtactg tgctggccaa catccaactg ctagtggcgt tcatggtatc 240
tttgttagcc atattagagg tggtcatggc tttgagattg gcatttcgca agagcctttt 300
gaccctagtg gttaccagct ttatttacat aaggctacta acggtaacac taatgctact 360
gcgcgactgc gcatttgcca gtttcctagc attaaaacat tgggccccac tgctaataat 420
gatgttacaa caggtcgtaa ttgcctattt aacaaagcca tcccagctca tatgagtgaa 480
catagtgttg tcggcataac atgggataat gatcgtgtca ctgtcttttc tgacaagatc 540
tattattttt attttaaaaa tgattggtcc cgtgttgcga caaagtgtta caacagtgga 600
ggttgtgcta tgcaatatgt ttacgaaccc acctattaca tgcttaatgt tactagtgct 660
ggtgaggatg gtatttctta tcaaccctgt acagctaatt gcattggtta ttctgccaat 720
gtatttgcta ctgagcccaa tggccacata ccagaaggtt ttagttttaa taattggttt 780
cttttgtcca atgattccac tttggtgcat ggtaaggtgg tttccaacca accattgttg 840
gtcaattgtc ttttggccat tcctaagatt tatggactag gccaattttt ctcctttaat 900
caaacgatcg atggtgtttg taatggagct gctgtgcagc gtgcaccaga ggctctgagg 960
tttaatatta atgacacctc tgtcattctt gctgaaggct caattgtact tcatactgct 1020
ttaggaacaa atttttcttt tgtttgcagt aattcctcag atcctcactt agccaccttc 1080
gccatacctc tgggtgctat ccaagtaccc tattattgtt ttcttaaagt ggatacttac 1140
aactccactg tttataaatt cttgtctgtt ttacctccta ccgtcaggga aattgtcatc 1200
accaagtatg gtgatgttta tgtcaatggg tttggctact tgcatctcgg tttgttggat 1260
gctgtcacaa ttaatttcac tggtcatggc actgacgatg acgtttctgg tttttggacc 1320
atagcatcga ctaattttgt tgatgcactt atcgaagttc aaggaactgc cattcagcgt 1380
attctttatt gtgatgatcc tgttagccaa ctcaagtgtt ctcaggttgc ttttgacctt 1440
gacgatggtt tctaccctat ttcttctaga aaccttctga gtcatgaaca gccaatttct 1500
tttgttgctt tgccatcatt taatgatcat tcttttgtta acattactgt ctctgcgtcc 1560
tttggtggtc atagtggtgc caaccttatt gcatctgaca ctactatcaa tgggtttagt 1620
tctttctgtg ttgacactag acaatttacc atttcactgt tttataacgt tacaaacagt 1680
tatggttatg tgtctaaatc acaggacagt aattgccctt tcaccttgca atctgttaat 1740
gattacctgt cttttagtaa attttgtgtt tccaccagcc ttttggctag tgcctgtacc 1800
atagatcttt ttggttaccc tgagtttggt agtggtgtta agtttacgtc cctttacttt 1860
caattcacaa agggtgagtt gattactggc acgtctaaac cacttgaagg tgtc 1914
<210> 5
<211> 1896
<212> DNA
<213>artificial synthesized (transmissible gastro-enteritis virus)
<400> 5
atgaaaaaac tatttgtggt tttggtcgta atgccattga tttatggaga caattttcct 60
tgttctaaat tgactaatag aactataggc aaccagtgga atctcattga aaccttcctt 120
ctaaactata gtagtaggtt accacctaat tcagatgtgg tgttaggtga ttattttcct 180
actgtacaac cttggtttaa ttgcattcgc aatgatagta atgaccttta tgttacactg 240
gaaaatctta aagcattgta ttgggattat gctacagaaa atatcacttg gaatcacaga 300
caacggttaa acgtagtcgt taatggatac ccatactcca tcacagttac aacaacccgc 360
aattttaatt ctgctgaagg tgctattata tgcatttgta agggctcacc acctactacc 420
accacagaat ctagtttgac ttgcaattgg ggtagtgagt gcaggttaaa ccataagttc 480
cctatatgtc cttctaattc agaggcaaat tgtggtaata tgctgtatgg cctacaatgg 540
tttgcagatg aggttgttgc ttatttacat ggtgctagtt accgtattag ttttgaaaat 600
caatggtctg gcactgtcac atttggtgat atgcgtgcga caacattaga agtcgctggc 660
acgcttgtag acctttggtg gtttaatcct gtttatgatg tcagttatta tagggttaat 720
aataaaaatg gtactaccgt agtttccaat tgcactgatc aatgtgctag ttatgtggct 780
aatgttttta ctacacagcc aggaggtttt ataccatcag attttagttt taataattgg 840
ttccttctaa ctaatagctc cacgttggtt agtggtaaat tagttaccaa acagccgtta 900
ttagttaatt gcttatggcc agtccctagc tttgaagaag cagcttctac attttgtttt 960
gagggtgctg gctttgatca atgtaatggt gctgttttaa ataatactgt agacgtcatt 1020
aggttcaacc ttaattttac tacaaatgta caatcaggta agggtgccac agtgttttca 1080
ttgaacacaa cgggtggtgt cactcttgaa atttcatgtt atacagtgag tgactcgagc 1140
tttttcagtt acggtgaaat tccgttcggc gtaactgatg gaccacggta ctgttacgta 1200
cactataatg gcacagctct taagtattta ggaacattac cacctagtgt caaggagatt 1260
gctattagta agtggggcca tttttatatt aatggttaca atttctttag cacatttcct 1320
attgattgta tatcttttaa tttgaccact ggtgatagtg acgttttctg gacaatagct 1380
tacacatcgt acactgaagc attagtacaa gttgaaaaca cagctattac aaaggtgacg 1440
tattgtaata gtcacgttaa taacattaaa tgctctcaaa ttactgctaa tttgaataat 1500
ggattttatc ctgtttcttc aagtgaagtt ggtcttgtca ataagagtgt tgtgttacta 1560
cctagctttt acacacatac cattgttaac ataactattg gtcttggtat gaagcgtagt 1620
ggttatggtc aacccatagc ctcaacatta agtaacatca cactaccaat gcaggatcac 1680
aacaccgatg tgtactgtat tcgttctgac caattttcag tttatgttca ttctacttgc 1740
aaaagtgctt tatgggacaa tatttttaag cgaaactgca cggacgtttt agatgccaca 1800
gctgttataa aaactggtac ttgtcctttc tcatttgata aattgaacaa ttacttaact 1860
tttaacaagt tctgtttgtc gttgagtcct gttggt 1896
<210> 6
<211> 1641
<212> DNA
<213>artificial synthesized (pig fourth type coronavirus)
<400> 6
atgcagagag ctctattgat tatgacctta ctttgtctcg ttcgagcaaa gtttgctgat 60
gatctactcg atttgctcac cttcccgggt gcacatcgct tcttacataa actcacgagt 120
aattccagca gtttctactc gcgggctaat aactttgatg ttggcgttct tcctggctac 180
cccactgaga acgttaacct cttctcacca cttactaact ctactttgcc aattaatggc 240
cttcatcgga gttaccaacc tcttatgctg aattgtctta ctaaaataac taaccamact 300
ctcagcatgt atctcctacc tagtgagata caaacttata gctgcggcgg tgccatggtt 360
aaataccaga cacatgatgc agttcgtatc attttagacc tcactgtcac tgaccacatc 420
tctgttgaag tcgttggcca acgtggtgaa aattatgtgt ttgtttgtag tgagcagttt 480
aactatacca ctgcattaca caactctacc ttcttctcac ttaattctga gctttattgc 540
tttactaata acacctactt aggtattctt ccacctgatt taactgactt tacggtctat 600
cgtactgggc agttttatgc taatggttac cttttaggta ctttacctat tacggttaac 660
tatgtaaggt tgtatcgggg tcatttgtcg gccaatagtg cccactttgc ccttgcaaac 720
ctaaccgata cactcataac acttaccaat actactatat cgcaaatcac ttattgtgat 780
aagtcagtag ttgattcaat agcatgccag cgctcttctc acgaagtgga ggatgggttt 840
tactccgacc ctaaatctgc cgttagagct aggcaacgta ctattgttac actacctaag 900
ctccctgagc ttgaagtagt gcagttaaat atttctgcac acatggattt tggcgaagcc 960
agacttgaca gcgttaccat caatggtaac acatcctatt gtgccactaa gccttacttc 1020
aggcttgaaa ctaactttat gtgtacaggt tgcactatga atctgcgcac tgatacctgt 1080
agttttgacc tgtcagcagt aaacaatggc atgtcattct ctcaattctg tctaagcact 1140
gaatctggtg cttgtgagat gaaaattatt gttacctacg tatggaatta cttgctaagg 1200
cagcgtttgt atgttacagc tgtagagggc cagactcaca ctggaaccac ttcagtacat 1260
gcaacagaca cttctagtgt aatcactgat gtctgcactg attacactat ctatggagtc 1320
tctggtactg gcattattaa gccatcagat ctcttattac ataatggcat agcattcacc 1380
tctccaacag gtgagctcta tgcatttaaa aatataacca ctggcaaaac ccttcaggtc 1440
ttaccgtgtg aaaccccttc tcaactgatt gtgataaaca acaccgttgt cggtgctatc 1500
acatccagta actcaactga aaataatagg tttactacta ctattgtcac acctactttc 1560
ttttattcca caaatgccac caccttcaac tgcaccaagc ctgttttgtc ctatggaccc 1620
atcagcgtgt gtagtgatgg t 1641

Claims (4)

1. sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus, feature exist In the vaccine includes antigen and vaccine adjuvant, and wherein antigen includes Porcine epidemic diarrhea virus S1 albumen, pig infection Property 1 albumen of gastroenteritis virus S and pig fourth type coronavirus S1 albumen;
The amino acid sequence of the Porcine epidemic diarrhea virus S1 albumen is SEQ ID NO:1;
The amino acid sequence of 1 albumen of pig infectious gastroenteritis virus S is SEQ ID NO:2;
The amino acid sequence of the pig fourth type coronavirus S1 albumen is SEQ ID NO:3;
The S1 of the S1 albumen of the Porcine epidemic diarrhea virus, 1 albumen of pig infectious gastroenteritis virus S and pig fourth type coronavirus The mass ratio of albumen is 1:1:1;
The Porcine epidemic diarrhea virus S1 albumen is the pichia pastoris yeast for being CGMCC NO:14372 by deposit number Bacterium expression preparation;1 albumen of pig infectious gastroenteritis virus S is the Bath for being CGMCC NO:14371 by deposit number The expression preparation of moral Pichia yeast;It is CGMCC NO:14370 that the pig fourth type coronavirus S1 albumen, which is by deposit number, Pichia Pastoris expression preparation.
2. pig epidemic diarrhea according to claim 1, transmissible gastroenteritis of swine, pig fourth type coronavirus disease three are sub- single Position vaccine, which is characterized in that the vaccine adjuvant be aluminium hydroxide gel, mineral oil, Gel 01, propolis, ISA206, ISA760VG or MF59.
3. pig epidemic diarrhea according to claim 1, transmissible gastroenteritis of swine, pig fourth type coronavirus disease three are sub- single Position vaccine, which is characterized in that the vaccine adjuvant is MF59.
4. pig epidemic diarrhea according to claim 1, transmissible gastroenteritis of swine, pig fourth type coronavirus disease three are sub- single Position vaccine, which is characterized in that Porcine epidemic diarrhea virus S1 protein content >=150 μ g/ml, pig in vaccine described in every part The S1 protein content of infectious gastroenteritis virus >=150 μ g/ml, S1 protein content >=150 μ g/ of pig fourth type coronavirus Ml, 50%(V/V) MF59.
CN201711093087.1A 2017-11-08 2017-11-08 Sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus Active CN107899008B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711093087.1A CN107899008B (en) 2017-11-08 2017-11-08 Sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711093087.1A CN107899008B (en) 2017-11-08 2017-11-08 Sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus

Publications (2)

Publication Number Publication Date
CN107899008A CN107899008A (en) 2018-04-13
CN107899008B true CN107899008B (en) 2019-05-10

Family

ID=61842795

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711093087.1A Active CN107899008B (en) 2017-11-08 2017-11-08 Sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus

Country Status (1)

Country Link
CN (1) CN107899008B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108315490B (en) * 2018-04-20 2022-03-11 咸阳职业技术学院 RT-PCR (reverse transcription-polymerase chain reaction) diagnostic kit for porcine acute diarrhea syndrome coronavirus and delta coronavirus and detection method thereof
CN110664749B (en) * 2019-10-21 2021-07-30 上海市皮肤病医院 MF 59-based entrapped antigen nanoemulsion and preparation method and application thereof
CN111073863B (en) * 2019-12-25 2022-03-01 武汉科前生物股份有限公司 Porcine epidemic diarrhea and porcine delta coronavirus bivalent attenuated vaccine and preparation method thereof
CN111607615B (en) * 2020-06-03 2022-03-01 金河佑本生物制品有限公司 Preparation method of porcine epidemic diarrhea and porcine transmissible gastroenteritis virus disease bivalent subunit vaccine
CN117414419B (en) * 2023-07-17 2024-06-11 浙江洪晟生物科技股份有限公司 Preparation method and application of triple inactivated vaccine for transmissible gastroenteritis, porcine epidemic diarrhea and porcine delta coronavirus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101491673A (en) * 2008-12-26 2009-07-29 天津瑞普生物技术股份有限公司 Triple vaccine of pig transmissible gastroenteritis, pig epidemic diarrhea and pig rotavirus
CN103041385B (en) * 2013-01-29 2014-02-19 齐鲁动物保健品有限公司 Porcine transmissible gastroenteritis and epidemic diarrhea combined live vaccine and preparation method thereof
CN103585625B (en) * 2013-11-29 2015-12-02 华南农业大学 A kind of porcine epizootic diarrhea recombinant baculovirus genetic engineering subunit vaccine and preparation method thereof and application
US10280199B2 (en) * 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
LT3166634T (en) * 2014-07-11 2021-11-10 Zoetis Services Llc Novel vaccine compositions for porcine epidemic diarrhea virus
CN106039304B (en) * 2016-05-28 2021-02-05 青岛易邦生物工程有限公司 Porcine parvovirus, porcine epidemic diarrhea and Escherichia coli triple vaccine
CN107158371A (en) * 2017-05-16 2017-09-15 青岛农业大学 A kind of gene engineered subunit bigeminy oral vaccine

Also Published As

Publication number Publication date
CN107899008A (en) 2018-04-13

Similar Documents

Publication Publication Date Title
CN107899008B (en) Sick three subunit vaccines of a kind of pig epidemic diarrhea, transmissible gastroenteritis of swine, pig fourth type coronavirus
CN110872578B (en) Variant infectious bursal disease virus, subunit vaccine, preparation method and application thereof
CN107337718A (en) A kind of gene for encoding carrying Cap gene of porcine circovirus type 2 and its application
CN109182380A (en) The preparation method and application of the swine fever E2 subunit vaccine of baculovirus expression
CN107412762B (en) Newcastle disease, avian influenza, bursa of fabricius and avian adenovirus quadruple vaccine
CN108823218A (en) Chicken infectivity bursa of Fabricius virus VP 2 gene, its expression product, its subunit vaccine and application
CN110183520A (en) A kind of brickpox SpaA albumen and its preparing the application in vaccine
CN112921005A (en) Hybridoma cell strain, canine parvovirus VP2 protein monoclonal antibody generated by hybridoma cell strain and application of monoclonal antibody
CN114163505B (en) Swine fever and porcine pseudorabies virus bigeminal subunit vaccine and preparation method thereof
CN106146626B (en) A kind of erysipelothrix ruhsiopathiae subunit vaccine and preparation method and application
CN105039233B (en) A kind of B. abortus molecular marker vaccine strain and its application
CN102727883B (en) Combined live vaccine against porcine reproductive and respiratory syndrome and swine fever, and application thereof
CN103352047B (en) Trichinella Spiralis larva ES antigen gene vaccine and preparation method
CN104610455A (en) Duck tembusu virus genetic engineering subunit vaccine
CN107779457A (en) Vaccine combination and its preparation method and application
CN103865884A (en) Duck viral hepatitis bivalent yolk antibody, preparation method and application thereof
CN105753949B (en) A kind of erysipelothrix rhusiopathiae antigen albumen and application
CN105535957A (en) Bivalent inactivated marker vaccine for foot-and-mouth disease type O and A, and preparation method thereof
CN109705223A (en) A kind of sheep of virus recombinant subunit vaccine and its production method
CN106039304B (en) Porcine parvovirus, porcine epidemic diarrhea and Escherichia coli triple vaccine
CN110013549A (en) A kind of Hepatitis E subunit vaccine
CN113861277A (en) Bovine rotavirus recombinant VP8 protein and application thereof
CN105833263A (en) Bivalent vaccine of acian metapneumovirus and H9 subtype avian influenza virus
CN100398150C (en) Toxoplasma metabolic secretion antigen vaccine and its prepn process
CN105879023B (en) Bivalent inactivated vaccine for porcine parvovirus and porcine epidemic diarrhea

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant